AQST — AQUESTIVE THERAPEUTICS INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying AQST?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 3 tracked investors who changed their AQST position last quarter, 0 bought and 3 sold (0% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 55/100 in a Squeeze regime).
- +1 tracked investors reported holding AQST at their latest filing
- +Macro Health is 55/100 in a Squeeze regime — historically acceptable for this sectorsource
- −3 tracked investors reduced or exited last quarter (1 reduced, 2 sold out)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/20/2026.
About AQUESTIVE THERAPEUTICS INC (AQST)
AQUESTIVE THERAPEUTICS INC (AQST) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $10M. Across recent filings, tracked investors recorded 3 new positions, 6 increased, 4 reduced, and 3 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in AQST
How many top investors track AQST
Only 1 tracked investor report this position.
AQST Ownership Composition
How AQUESTIVE THERAPEUTICS INC is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant100.0%
Tracked investors currently reporting AQST
2 tracked investors have since exited this position — listed separately below.
- Ken GriffinJun 30, 2026Citadel AdvisorsShares710.9KValue$3M% Portfolio0.00%
Previously held AQST
These investors reported AQST in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Izzy Englander | Millennium Management | 25.9K | $107.3K | Mar 31, 2026 |
| Steve Cohen | Point72 Asset Management | 283.7K | $1.2M | Mar 31, 2026 |
Recent activity
- Reduced$205.7K(-54.55%)Nov 14, 2024
- Increased$310.5K(111.20%)Feb 14, 2025
- Increased$748.8K(196.03%)May 15, 2025
- Increased$9.9M(1054.01%)Aug 14, 2025
- Increased$9.9M(19.08%)Feb 17, 2026
- Reduced$107.3K(-98.32%)May 15, 2026
- Sold$0(-100.00%)Aug 14, 2026
- Increased$5M(255.32%)Nov 14, 2024
- Increased$1.7M(28.30%)May 15, 2025
- Reduced$931K(-52.85%)Aug 14, 2025
- Sold$0(-100.00%)Nov 14, 2025
- Reduced$3M(-30.27%)Aug 14, 2026
- New$1.2MMay 15, 2026
- Sold$0(-100.00%)Aug 14, 2026
- New$736.9KAug 14, 2024
- $2.1MMay 15, 2024
Frequently asked questions
- How many institutional investors hold AQST?
- 1 tracked institutional investor disclosed a position in AQST (AQUESTIVE THERAPEUTICS INC) in their most recent 13F filing.
- Who is the largest institutional holder of AQST?
- Izzy Englander, Millennium Management, holds the largest disclosed position in AQST, valued at $10M.
- Did institutional ownership of AQST increase or decrease?
- Across recent 13F filings, tracked investors recorded 3 new positions, 6 increased, 4 reduced, and 3 fully exited AQST.
- Where does this AQST ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.